BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation announced the promotion of Vice President of Service Delivery Andrea Valente to Chief Operating Officer. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
PHT President and CEO Philip Lee said, “Since Andrea joined PHT she has consistently demonstrated her commitment and ability to transform the Service Delivery organization to provide higher value and greater benefit for PHT clients. Andrea is the ideal executive to guide PHT operations as the company embarks on an important new phase of growth and product development.”
Prior to PHT Andrea was Vice President of Global Services, Education and Customer Support at OpenPages, where she led bookings and delivery of all global services, education and support of governance, risk and compliance software products. Previously Andrea was Vice President of North American Services at Phase Forward, where she was responsible for all U.S.-based service in support of eClinical trial management software products.
Andrea Valente said, “PHT operates with a culture of customer focus and responsiveness with the utmost priority on high levels of customer satisfaction. I look forward to helping bring PHT to the next level of operational excellence as we continue to innovate and make patient-driven eData systems easier to use for all participants in the clinical research process to support increased adoption and growth.”
Registration is open for the PRO & eCOA Congress, Europe, 3-5 June in Barcelona, Spain. Learn more here: http://bit.ly/CongressBarcelona. Meet PHT at the Outsourcing in Clinical Trials Europe, 21-22 May to be entered to win one free PRO & eCOA Congress registration and hotel accommodation in Barcelona. Join the PRO & eCOA Congress LinkedIn Community.
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.